The bacterial second messenger cdiGMP exhibits promising activity as a mucosal adjuvant

Clinical and Vaccine Immunology

Volumn 14, Issue 8, 2007, Pages 952-958

  Ebensen, Thomas ^a   Schulze, Kai ^a   Riese, Peggy ^a   Morr, Michael ^a   Guzmán, Carlos A ^a  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; BIS(3',5') CYCLIC DIMERIC GMP; CYCLIC GMP DERIVATIVE; DIMER; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; OVALBUMIN; UNCLASSIFIED DRUG; CYCLIC GMP; DRUG DERIVATIVE; IMMUNOLOGICAL ADJUVANT; SECRETORY IMMUNOGLOBULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; IMMUNIZATION; LUNG LAVAGE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SECOND MESSENGER; VACCINE PRODUCTION; VAGINAL LAVAGE; ANIMAL; BAGG ALBINO MOUSE; BLOOD; C57BL MOUSE; CYTOTOXICITY; IMMUNOLOGY; INTRANASAL DRUG ADMINISTRATION; LUNG; MUCOSAL IMMUNITY; VAGINA;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ANIMALS; BETA-GALACTOSIDASE; CYCLIC GMP; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; IMMUNITY, MUCOSAL; IMMUNIZATION; IMMUNOGLOBULIN A, SECRETORY; IMMUNOGLOBULIN G; LUNG; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; OVALBUMIN; SECOND MESSENGER SYSTEMS; T-LYMPHOCYTES, CYTOTOXIC; VAGINA;

EID: 34948813217     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00119-07     Document Type: Article

References (45)

1. Borsutzky, S., T. Ebensen, C. Link, P. D. Becker, V. Fiorelli, A. Cafaro, B. Ensoli, and C. A. Guzman. 2006. Efficient systemic and mucosal responses against the HIV-1 Tat protein by prime/boost vaccination using the lipopeptide MALP-2 as adjuvant. Vaccine 24:2049-2056.
2. Borsutzky, S., V. Fiorelli, T. Ebensen, A. Tripiciano, F. Rharbaoui, A. Scoglio, C. Link, F. Nappi, M. Morr, S. Butto, A. Cafaro, P. F. Muhlradt, B. Ensoli, and C. A. Guzman. 2003. Efficient mucosal delivery of the HIV-1 Tat protein using the synthetic lipopeptide MALP-2 as adjuvant. Eur. J. Immunol. 33:1548-1556.
3. Braun, S. E., K. Chen, R. G. Foster, C. H. Kim, R. Hromas, M. H. Kaplan, H. E. Broxmeyer, and K. Cornetta. 2000. The CC chemokine CK beta-11/MIP-3 beta/ELC/Exodus 3 mediates tumor rejection of murine breast cancer cells through NK cells. J. Immunol. 164:4025-4031.
4. Burdin, N., B. Guy, and P. Moingeon. 2004. Immunological foundations to the quest for new vaccine adjuvants. BioDrugs 18:79-93.
5. Cavallo, F., A. Astolfi, M. Iezzi, F. Cordero, P. L. Lollini, G. Forni, and R. Calogero. 2005. An integrated approach of immunogenomics and bioinformatics to identify new tumor associated antigens (TAA) for mammary cancer immunological prevention. BMC Bioinformatics 6(Suppl. 4):S7.
6. Di Guilmi, A. M., and A. Dessen. 2002. New approaches towards the identification of antibiotic and vaccine targets in Streptococcus pneumoniae. EMBO Rep. 3:728-734.
7. Drabner, B., and C. A. Guzman. 2001. Elicitation of predictable immune responses by using live bacterial vectors. Biomol. Eng. 17:75-82.
8. Ebensen, T., S. Paukner, C. Link, P. Kudela, C. de Domenico, W. Lubitz, and C. A. Guzman. 2004. Bacterial ghosts are an efficient delivery system for DNA vaccines. J. Immunol. 172:6858-6865.
9. Ebensen, T., K. Schulze, P. Riese, C. Link, M. Morr, and C. A. Guzman. 2007. The bacterial second messenger cyclic diGMP exhibits potent adjuvant properties. Vaccine 25:1464-1469.
10. Fearon, D. T., and R. M. Locksley. 1996. The instructive role of innate immunity in the acquired immune response. Science 272:50-53.
11. Guy, B., and N. Burdin. 2005. New adjuvants for parenteral and mucosal vaccines. Therapie 60:235-241.
12. Hermans, I. F., J. D. Silk, J. Yang, M. J. Palmowski, U. Gileadi, C. Mc-Carthy, M. Salio, F. Ronchese, and V. Cerundolo. 2004. The VITAL assay: a versatile fluorometric technique for assessing CTL- and NKT-mediated cytotoxicity against multiple targets in vitro and in vivo. J. Immunol. Methods 285:25-40.
13. Hickman, J. W., D. F. Tifrea, and C. S. Harwood. 2005. A chemosensory system that regulates biofilm formation through modulation of cyclic diguanylate levels. Proc. Natl. Acad. Sci. USA 102:14422-14427.
14. Hsu, C.-Y., D. Dennis, and R. A. Jones. 1985. Synthesis and physical characterization of bis 3′5′ cyclic dinucleotides (-NpNp-): RNA polymerase inhibitors. Nucleosides Nucleotides 4(3):377-389.
15. Inngjerdingen, M., B. Damaj, and A. A. Maghazachi. 2001. Expression and regulation of chemokine receptors in human natural killer cells. Blood 97:367-375.
16. Inngjerdingen, M., B. Damaj, and A. A. Maghazachi. 2000. Human NK cells express CC chemokine receptors 4 and 8 and respond to thymus and activation-regulated chemokine, macrophage-derived chemokine, and I-309. J. Immunol. 164:4048-4054.
17. Karaolis, D. K., K. Cheng, M. Lipsky, A. Elnabawi, J. Catalano, M. Hyodo, Y. Hayakawa, and J. P. Raufman. 2005. 3′,5′-Cyclic diguanylic acid (c-di-GMP) inhibits basal and growth factor-stimulated human colon cancer cell proliferation. Biochem. Biophys. Res. Commun. 329:40-45.
18. Karaolis, D. K., T. K. Means, D. Yang, M. Takahashi, T. Yoshimura, E. Muraille, D. Philpott, J. T. Schroeder, M. Hyodo, Y. Hayakawa, B. G. Talbot, E. Brouillette, and F. Malouin. 2007. Bacterial c-di-GMP is an immunostimulatory molecule. J. Immunol. 178:2171-2181.
19. Kawaguchi, M., M. Adachi, N. Oda, F. Kokubu, and S. K. Huang. 2004. IL-17 cytokine family. J. Allergy Clin. Immunol. 114:1265-1273, 1274.
20. Kawaguchi, M., F. Kokubu, M. Odaka, S. Watanabe, S. Suzuki, K. Ieki, S. Matsukura, M. Kurokawa, M. Adachi, and S. K. Huang. 2004. Induction of granulocyte-macrophage colony-stimulating factor by a new cytokine, ML-1 (IL-17F), via Raf I-MEK-ERK pathway. J. Allergy Clin. Immunol. 114:444-450.
21. Kelly, M. N., J. K. Kolls, K. Happel, J. D. Schwartzman, P. Schwarzenberger, C. Combe, M. Moretto, and I. A. Khan. 2005. Interleukin-17/interleukin-17 receptor-mediated signaling is important for generation of an optimal polymorphonuclear response against Toxoplasma gondii infection. Infect. Immun. 73:617-621.
22. Kolls, J. K., and A. Linden. 2004. Interleukin-17 family members and inflammation. Immunity 21:467-476.
23. Lavelle, E. C. 2005. Generation of improved mucosal vaccines by induction of innate immunity. Cell. Mol. Life Sci. 62:2750-2770.
24. Lizotte-Waniewski, M., W. Tawe, D. B. Guiliano, W. Lu, J. Liu, S. A. Williams, and S. Lustigman. 2000. Identification of potential vaccine and drug target candidates by expressed sequence tag analysis and immunoscreening of Onchocerca volvulus larval cDNA libraries. Infect. Immun. 68:3491-3501.
25. Luther, S. A., and J. G. Cyster. 2001. Chemokines as regulators of T cell differentiation. Nat. Immunol. 2:102-107.
26. Matloubian, M., A. David, S. Engel, J. E. Ryan, and J. G. Cyster. 2000. A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo. Nat. Immunol. 1:298-304.
27. Maurer, M., and E. von Stebut. 2004. Macrophage inflammatory protein-1. Int. J. Biochem. Cell Biol. 36:1882-1886.
28. Medina, E., and C. A. Guzman. 2000. Modulation of immune responses following antigen administration by mucosal route. FEMS Immunol. Med. Microbiol. 27:305-311.
29. Miller, M. B., and B. L. Bassler. 2001. Quorum sensing in bacteria. Annu. Rev. Microbiol. 55:165-199.
30. Reading, N. C., and V. Sperandio. 2006. Quorum sensing: the many languages of bacteria. FEMS Microbiol. Lett. 254:1-11.
31. Ross, P., R. Mayer, and M. Benziman. 1991. Cellulose biosynthesis and function in bacteria. Microbiol. Rev. 55:35-58.
32. Ross, P., R. Mayer, H. Weinhouse, D. Amikam, Y. Huggirat, M. Benziman, E. de Vroom, A. Fidder, P. de Paus, L. A. Sliedregt, et al. 1990. The cyclic diguanylic acid regulatory system of cellulose synthesis in Acetobacter xylinum. Chemical synthesis and biological activity of cyclic nucleotide dimer, trimer, and phosphothioate derivatives. J. Biol. Chem. 265:18933-18943.
33. Salazar-Mather, T. P., J. S. Orange, and C. A. Biron. 1998. Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1alpha (MIP-1alpha)-dependent pathways. J. Exp. Med. 187:1-14.
34. Simm, R., J. D. Fetherston, A. Kader, U. Romling, and R. D. Perry. 2005. Phenotypic convergence mediated by GGDEF-domain-containing proteins. J. Bacteriol. 187:6816-6823.
35. Simm, R., M. Morr, A. Kader, M. Nimtz, and U. Romling. 2004. GGDEF and EAL domains inversely regulate cyclic di-GMP levels and transition from sessility to motility. Mol. Microbiol. 53:1123-1134.
36. Stanic, A. K., A. D. De Silva, J. J. Park, V. Sriram, S. Ichikawa, Y. Hirabyashi, K. Hayakawa, L. Van Kaer, R. R. Brutkiewicz, and S. Joyce. 2003. Defective presentation of the CD1d1-restricted natural Va14Ja18 NKT lymphocyte antigen caused by beta-D-glucosylceramide synthase deficiency. Proc. Natl. Acad. Sci. USA 100:1849-1854.
37. Stevceva, L., and M. G. Ferrari. 2005. Mucosal adjuvants. Curr. Pharm. Des. 11:801-811.
38. Sullivan, V. J., J. A. Mikszta, P. Laurent, J. Huang, and B. Ford. 2006. Noninvasive delivery technologies: respiratory delivery of vaccines. Expert Opin. Drug Deliv. 3:87-95.
39. Teicher, B. A. 2000. Molecular targets and cancer therapeutics: discovery, development and clinical validation. Drug Resist. Updat. 3:67-73.
40. Tischler, A. D., and A. Camilli. 2004. Cyclic diguanylate (c-di-GMP) regulates Vibrio cholerae biofilm formation. Mol. Microbiol. 53:857-869.
41. Tischler, A. D., and A. Camilli. 2005. Cyclic diguanylate regulates Vibrio cholerae virulence gene expression. Infect. Immun. 73:5873-5882.
42. Witowski, J., K. Ksiazek, and A. Jorres. 2004. Interleukin-17: a mediator of inflammatory responses. Cell. Mol. Life Sci. 61:567-579.
43. Zareba, G. 2006. A new combination vaccine for measles, mumps, rubella and varicella. Drugs Today (Barcelona) 42:321-329.
44. Zeng, F., and R. Jones. 1996. Synthesis of cyclic dinucleotides by an Hphosphonate method in solution. Nucleosides Nucleotides 15:1679-1686.
45. Zou, G. M., and Y. K. Tam. 2002. Cytokines in the generation and maturation of dendritic cells: recent advances. Eur. Cytok. Netw. 13:186-199.